Cargando…
Heat shock protein 70–2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth
BACKGROUND: Colorectal cancer (CRC) is the third leading cause of cancer related deaths worldwide both in men and women. Our recent studies have indicated an association of heat shock protein 70–2 (HSP70-2) with bladder urothelial carcinoma. In the present study, we investigated the association of H...
Autores principales: | Jagadish, Nirmala, Parashar, Deepak, Gupta, Namita, Agarwal, Sumit, Suri, Vaishali, Kumar, Rajive, Suri, Vitusha, Sadasukhi, Trilok Chand, Gupta, Anju, Ansari, Abdul S., Lohiya, Nirmal Kumar, Suri, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966739/ https://www.ncbi.nlm.nih.gov/pubmed/27473057 http://dx.doi.org/10.1186/s12885-016-2592-7 |
Ejemplares similares
-
Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer
por: Jagadish, Nirmala, et al.
Publicado: (2016) -
Sperm Associated Antigen 9 Plays an Important Role in Bladder Transitional Cell Carcinoma
por: Kanojia, Deepika, et al.
Publicado: (2013) -
The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma
por: Agarwal, Sumit, et al.
Publicado: (2013) -
Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy
por: Sinha, Abhilasha, et al.
Publicado: (2013) -
Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)